Stroke risk and COVID-19

Stroke is comparatively frequent among patients with COVID-19 and has devastating consequences across all ages. The interaction of older age, comorbid conditions, and severity of COVID-19 metabolic process symptoms are related to very elevated mortality. Acute vessel disease, significantly anaemia stroke, has emerged as a heavy complication of infection by the severe acute respiratory syndrome coronavirus a pair of, the etiologic agent of the Coronavirus disease‐2019.

  • Therapy for communication disorders
  • Psychological evaluation and treatment

Related Conference of Stroke risk and COVID-19

January 29-30, 2026

29th International Conference on Viral Infections & Virology

Aix-en-Provence, France
February 02-03, 2026

7th Global Summit on Brain Disorders and Therapeutics

Paris, France
February 12-13, 2026

8th World Conference on Neuroscience

Singapore City, Singapore
March 09-10, 2026

7th International Conference on Neurologists

Singapore City, Singapore
April 23-24, 2026

8th World Depression Congress

Paris, France
May 14-15, 2026

9th World Conference on Neuroscience

Rome, Italy
May 18-19, 2026

38th International conference on Mental Health and Psychiatry

Aix-en-Provence, France
June 22-23, 2026

7th World Congress on Sleep Disorders and Therapeutics

Amsterdam, Netherlands
June 22-23, 2026

38th World Conference on Neurology

Barcelona, Spain
June 29-30, 2026

39th European Neurology Congress

London, UK
June 29-30, 2026

37th Conference on Clinical Neuroscience and Neurogenetics

Aix-en-Provence, France
July 20-21, 2026

37th World Congress on Neurology and Neuroscience

Amsterdam, Netherlands
July 23-24, 2026

16th Global Alzheimers Summit

Paris, France
July 23-24, 2026

14th International Conference on Cannabis & Medicinal Research

Amsterdam, Netherlands
September 18-19, 2026

21st Annual Congress on Neuroscience

Dubai, UAE

Stroke risk and COVID-19 Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in